BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17198283)

  • 1. Rejuvenating a foundering institutional review board: one institution's story.
    De Ville K; Hassler G; Lewis MJ
    Acad Med; 2007 Jan; 82(1):11-7. PubMed ID: 17198283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Searching for an efficient institutional review board review model: Interrelationship of trainee-investigators, funding, and initial approval.
    Dominguez RA; Feaster DJ; Twiggs LB; Altman NH
    J Lab Clin Med; 2005 Feb; 145(2):65-71. PubMed ID: 15746648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical education research and IRB review: an analysis and comparison of the IRB review process at six institutions.
    Dyrbye LN; Thomas MR; Mechaber AJ; Eacker A; Harper W; Massie FS; Power DV; Shanafelt TD
    Acad Med; 2007 Jul; 82(7):654-60. PubMed ID: 17595560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in institutional review board responses to a standard, observational, pediatric research protocol.
    Mansbach J; Acholonu U; Clark S; Camargo CA
    Acad Emerg Med; 2007 Apr; 14(4):377-80. PubMed ID: 17312334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concept paper: a virtual centralized IRB system.
    McWilliams R; Hebden CW; Gilpin AM
    Account Res; 2006; 13(1):25-45. PubMed ID: 16770858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontario Cancer Research Ethics Board: lessons learned from developing a multicenter regional institutional review board.
    Saginur R; Dent SF; Schwartz L; Heslegrave R; Stacey S; Manzo J
    J Clin Oncol; 2008 Mar; 26(9):1479-82. PubMed ID: 18349399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Institutional review board consideration of chart reviews, case reports, and observational studies.
    Neff MJ
    Respir Care; 2008 Oct; 53(10):1350-3. PubMed ID: 18811999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinician educators' experiences with institutional review boards: results of a national survey.
    Dyrbye LN; Thomas MR; Papp KK; Durning SJ
    Acad Med; 2008 Jun; 83(6):590-5. PubMed ID: 18520468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing procedures for institutional oversight of stem cell research.
    Zettler P; Wolf LE; Lo B
    Acad Med; 2007 Jan; 82(1):6-10. PubMed ID: 17198282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical and institutional review board issues.
    Skolnick BE
    Adv Neurol; 1998; 76():253-62. PubMed ID: 9408484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protecting subjects, preserving trust, promoting progress II: principles and recommendations for oversight of an institution's financial interests in human subjects research.
    AAMC Task Force on Financial Conflicts of Interest in Clinical Research
    Acad Med; 2003 Feb; 78(2):237-45. PubMed ID: 12584107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should society allow research ethics boards to be run as for-profit enterprises?
    Emanuel EJ; Lemmens T; Elliot C
    PLoS Med; 2006 Jul; 3(7):e309. PubMed ID: 16848618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practice-based research network studies and institutional review boards: two new issues.
    Yawn BP; Graham DG; Bertram SL; Kurland MJ; Dietrich AJ; Wollan PC; Brandt EC; Huff JM; Pace WD
    J Am Board Fam Med; 2009; 22(4):453-60. PubMed ID: 19587261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anonymous self-evaluation of performance by ethics board members: a pilot study.
    Feldman JA; Rebholz CM
    J Empir Res Hum Res Ethics; 2009 Mar; 4(1):63-9. PubMed ID: 19382879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of human subjects: categories of research that may be reviewed by the Institutional Review Board (IRB) through an expedited review procedure--FDA. Notice.
    Fed Regist; 1998 Nov; 63(216 Pt 1):60353-6. PubMed ID: 10187395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reporting of ethical review of clinical research submitted to the Journal of the American Academy of Dermatology.
    Perkins AC; Choi JM; Kimball AB
    J Am Acad Dermatol; 2007 Feb; 56(2):279-84. PubMed ID: 17224370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New challenges facing interinstitutional social science and educational program evaluation research at academic health centers: a case study from the ELAM program.
    Morahan PS; Yamagata H; McDade SA; Richman R; Francis R; Odhner VC
    Acad Med; 2006 Jun; 81(6):527-34. PubMed ID: 16728800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An education initiative to increase staff knowledge of Institutional Review Board guidelines in the USA.
    Kotzer AM; Milton J
    Nurs Health Sci; 2007 Jun; 9(2):103-6. PubMed ID: 17470183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing communication among data monitoring committees and institutional review boards.
    Taylor HA; Chaisson L; Sugarman J
    Clin Trials; 2008; 5(3):277-82. PubMed ID: 18559418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.